ID   IP3KB_HUMAN             Reviewed;         946 AA.
AC   P27987; Q5VWL9; Q5VWM0; Q96BZ2; Q96JS1; Q9UH47;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2005, sequence version 5.
DT   10-MAY-2017, entry version 157.
DE   RecName: Full=Inositol-trisphosphate 3-kinase B;
DE            EC=2.7.1.127;
DE   AltName: Full=Inositol 1,4,5-trisphosphate 3-kinase B;
DE            Short=IP3 3-kinase B;
DE            Short=IP3K B;
DE            Short=InsP 3-kinase B;
GN   Name=ITPKB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ALA-408 AND
RP   GLN-552.
RC   TISSUE=Hippocampus;
RX   PubMed=11846419; DOI=10.1006/bbrc.2002.6456;
RA   Dewaste V., Roymans D., Moreau C., Erneux C.;
RT   "Cloning and expression of a full-length cDNA encoding human inositol
RT   1,4,5-trisphosphate 3-kinase B.";
RL   Biochem. Biophys. Res. Commun. 291:400-405(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLN-552.
RC   TISSUE=Colon;
RA   Bertsch U., Suesse S., Frerk S., Fanick W.;
RT   "Cloning of the complete protein coding regions for inositol 1,4,5-
RT   trisphosphate 3-kinase B-isoforms from rat and human.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS
RP   ALA-408 AND GLN-552.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 442-946 (ISOFORM 1), AND VARIANT
RP   GLN-552.
RC   TISSUE=Hippocampus;
RX   PubMed=1654894; DOI=10.1042/bj2780883;
RA   Takazawa K., Perret J., Dumont J.E., Erneux C.;
RT   "Molecular cloning and expression of a new putative inositol 1,4,5-
RT   trisphosphate 3-kinase isoenzyme.";
RL   Biochem. J. 278:883-886(1991).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43 AND SER-49, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43; SER-49 AND SER-71,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   INTERACTION WITH DMTN.
RX   PubMed=23060452; DOI=10.1074/jbc.M112.364679;
RA   Wieschhaus A.J., Le Breton G.C., Chishti A.H.;
RT   "Headpiece domain of dematin regulates calcium mobilization and
RT   signaling in platelets.";
RL   J. Biol. Chem. 287:41218-41231(2012).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CATALYTIC ACTIVITY: ATP + 1D-myo-inositol 1,4,5-trisphosphate =
CC       ADP + 1D-myo-inositol 1,3,4,5-tetrakisphosphate.
CC   -!- ENZYME REGULATION: IP3K is activated by calmodulin. Form B is much
CC       more sensitive to calcium/calmodulin than form A.
CC   -!- SUBUNIT: Interacts with DMTN. {ECO:0000269|PubMed:23060452}.
CC   -!- INTERACTION:
CC       Q08379:GOLGA2; NbExp=4; IntAct=EBI-751388, EBI-618309;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P27987-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P27987-2; Sequence=VSP_016092;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the inositol phosphokinase (IPK) family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA40491.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y18024; CAB65055.3; -; mRNA.
DR   EMBL; AJ242780; CAC40650.1; -; mRNA.
DR   EMBL; AL365444; CAH70187.1; -; Genomic_DNA.
DR   EMBL; AL365444; CAH70188.1; -; Genomic_DNA.
DR   EMBL; BC015009; AAH15009.1; -; mRNA.
DR   EMBL; X57206; CAA40491.1; ALT_INIT; mRNA.
DR   CCDS; CCDS1555.1; -. [P27987-1]
DR   PIR; JC7810; JC7810.
DR   PIR; S17682; S17682.
DR   RefSeq; NP_002212.3; NM_002221.3. [P27987-1]
DR   RefSeq; XP_005273177.1; XM_005273120.2. [P27987-2]
DR   UniGene; Hs.528087; -.
DR   UniGene; Hs.659396; -.
DR   UniGene; Hs.690477; -.
DR   ProteinModelPortal; P27987; -.
DR   SMR; P27987; -.
DR   BioGrid; 109912; 8.
DR   IntAct; P27987; 13.
DR   MINT; MINT-1454586; -.
DR   STRING; 9606.ENSP00000272117; -.
DR   iPTMnet; P27987; -.
DR   PhosphoSitePlus; P27987; -.
DR   BioMuta; ITPKB; -.
DR   DMDM; 62906885; -.
DR   EPD; P27987; -.
DR   MaxQB; P27987; -.
DR   PaxDb; P27987; -.
DR   PeptideAtlas; P27987; -.
DR   PRIDE; P27987; -.
DR   Ensembl; ENST00000272117; ENSP00000272117; ENSG00000143772. [P27987-1]
DR   Ensembl; ENST00000366784; ENSP00000355748; ENSG00000143772. [P27987-2]
DR   Ensembl; ENST00000429204; ENSP00000411152; ENSG00000143772. [P27987-1]
DR   GeneID; 3707; -.
DR   KEGG; hsa:3707; -.
DR   UCSC; uc001hqh.4; human. [P27987-1]
DR   CTD; 3707; -.
DR   DisGeNET; 3707; -.
DR   GeneCards; ITPKB; -.
DR   H-InvDB; HIX0001645; -.
DR   HGNC; HGNC:6179; ITPKB.
DR   HPA; HPA030273; -.
DR   HPA; HPA072923; -.
DR   MIM; 147522; gene.
DR   neXtProt; NX_P27987; -.
DR   OpenTargets; ENSG00000143772; -.
DR   PharmGKB; PA29976; -.
DR   eggNOG; KOG1621; Eukaryota.
DR   eggNOG; ENOG410Y8AC; LUCA.
DR   GeneTree; ENSGT00390000017438; -.
DR   HOGENOM; HOG000060305; -.
DR   HOVERGEN; HBG052139; -.
DR   InParanoid; P27987; -.
DR   KO; K00911; -.
DR   OMA; QGQFLGS; -.
DR   OrthoDB; EOG091G03J3; -.
DR   PhylomeDB; P27987; -.
DR   TreeFam; TF318394; -.
DR   BioCyc; MetaCyc:HS07103-MONOMER; -.
DR   BRENDA; 2.7.1.127; 2681.
DR   Reactome; R-HSA-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   SIGNOR; P27987; -.
DR   ChiTaRS; ITPKB; human.
DR   GeneWiki; ITPKB; -.
DR   GenomeRNAi; 3707; -.
DR   PRO; PR:P27987; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143772; -.
DR   CleanEx; HS_ITPKB; -.
DR   Genevisible; P27987; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0008440; F:inositol-1,4,5-trisphosphate 3-kinase activity; IDA:UniProtKB.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB.
DR   GO; GO:0035726; P:common myeloid progenitor cell proliferation; IEA:Ensembl.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome.
DR   GO; GO:0032957; P:inositol trisphosphate metabolic process; IDA:UniProtKB.
DR   GO; GO:0000165; P:MAPK cascade; IEA:Ensembl.
DR   GO; GO:0002262; P:myeloid cell homeostasis; IEA:Ensembl.
DR   GO; GO:0045638; P:negative regulation of myeloid cell differentiation; IEA:Ensembl.
DR   GO; GO:0033030; P:negative regulation of neutrophil apoptotic process; IEA:Ensembl.
DR   GO; GO:0046638; P:positive regulation of alpha-beta T cell differentiation; IEA:Ensembl.
DR   GO; GO:0046579; P:positive regulation of Ras protein signal transduction; IEA:Ensembl.
DR   GO; GO:0045059; P:positive thymic T cell selection; IEA:Ensembl.
DR   GO; GO:0001932; P:regulation of protein phosphorylation; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR005522; IPK.
DR   PANTHER; PTHR12400; PTHR12400; 1.
DR   Pfam; PF03770; IPK; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Calmodulin-binding;
KW   Complete proteome; Kinase; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transferase.
FT   CHAIN         1    946       Inositol-trisphosphate 3-kinase B.
FT                                /FTId=PRO_0000066868.
FT   NP_BIND     730    732       ATP. {ECO:0000250}.
FT   REGION      768    776       Calmodulin-binding. {ECO:0000250}.
FT   REGION      793    800       Substrate binding. {ECO:0000250}.
FT   COMPBIAS    599    605       Poly-Ser.
FT   BINDING     679    679       ATP. {ECO:0000250}.
FT   BINDING     690    690       ATP. {ECO:0000250}.
FT   BINDING     743    743       ATP. {ECO:0000250}.
FT   BINDING     745    745       Substrate. {ECO:0000250}.
FT   BINDING     766    766       Substrate. {ECO:0000250}.
FT   BINDING     817    817       ATP. {ECO:0000250}.
FT   BINDING     897    897       ATP. {ECO:0000250}.
FT   BINDING     900    900       Substrate. {ECO:0000250}.
FT   MOD_RES      43     43       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18669648}.
FT   MOD_RES      49     49       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18669648}.
FT   MOD_RES      71     71       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     204    204       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P42335}.
FT   MOD_RES     269    269       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P42335}.
FT   VAR_SEQ     645    946       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_016092.
FT   VARIANT     322    322       A -> T (in dbSNP:rs3754413).
FT                                /FTId=VAR_053444.
FT   VARIANT     408    408       S -> A (in dbSNP:rs6667260).
FT                                {ECO:0000269|PubMed:11846419,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_023768.
FT   VARIANT     552    552       P -> Q (in dbSNP:rs708776).
FT                                {ECO:0000269|PubMed:11846419,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:1654894,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_022380.
FT   CONFLICT    173    173       R -> H (in Ref. 2; CAC40650 and 4;
FT                                AAH15009). {ECO:0000305}.
FT   CONFLICT    210    210       P -> S (in Ref. 2; CAC40650).
FT                                {ECO:0000305}.
FT   CONFLICT    297    301       GASLT -> APSFP (in Ref. 2; CAC40650).
FT                                {ECO:0000305}.
FT   CONFLICT    442    443       RV -> IP (in Ref. 5). {ECO:0000305}.
SQ   SEQUENCE   946 AA;  102376 MW;  2CCBCBE7AEF26848 CRC64;
     MAVYCYALNS LVIMNSANEM KSGGGPGPSG SETPPPPRRA VLSPGSVFSP GRGASFLFPP
     AESLSPEEPR SPGGWRSGRR RLNSSSGSGS GSSGSSVSSP SWAGRLRGDR QQVVAAGTLS
     PPGPEEAKRK LRILQRELQN VQVNQKVGMF EAHIQAQSSA IQAPRSPRLG RARSPSPCPF
     RSSSQPPGRV LVQGARSEER RTKSWGEQCP ETSGTDSGRK GGPSLCSSQV KKGMPPLPGR
     AAPTGSEAQG PSAFVRMEKG IPASPRCGSP TAMEIDKRGS PTPGTRSCLA PSLGLFGASL
     TMATEVAARV TSTGPHRPQD LALTEPSGRA RELEDLQPPE ALVERQGQFL GSETSPAPER
     GGPRDGEPPG KMGKGYLPCG MPGSGEPEVG KRPEETTVSV QSAESSDSLS WSRLPRALAS
     VGPEEARSGA PVGGGRWQLS DRVEGGSPTL GLLGGSPSAQ PGTGNVEAGI PSGRMLEPLP
     CWDAAKDLKE PQCPPGDRVG VQPGNSRVWQ GTMEKAGLAW TRGTGVQSEG TWESQRQDSD
     ALPSPELLPQ DPDKPFLRKA CSPSNIPAVI ITDMGTQEDG ALEETQGSPR GNLPLRKLSS
     SSASSTGFSS SYEDSEEDIS SDPERTLDPN SAFLHTLDQQ KPRVSKSWRK IKNMVHWSPF
     VMSFKKKYPW IQLAGHAGSF KAAANGRILK KHCESEQRCL DRLMVDVLRP FVPAYHGDVV
     KDGERYNQMD DLLADFDSPC VMDCKMGIRT YLEEELTKAR KKPSLRKDMY QKMIEVDPEA
     PTEEEKAQRA VTKPRYMQWR ETISSTATLG FRIEGIKKED GTVNRDFKKT KTREQVTEAF
     REFTKGNHNI LIAYRDRLKA IRTTLEVSPF FKCHEVIGSS LLFIHDKKEQ AKVWMIDFGK
     TTPLPEGQTL QHDVPWQEGN REDGYLSGLN NLVDILTEMS QDAPLA
//
